ATE438657T1 - Charakterisierung von granulozytischer ehrlichia und methoden für ihre verwendung. - Google Patents

Charakterisierung von granulozytischer ehrlichia und methoden für ihre verwendung.

Info

Publication number
ATE438657T1
ATE438657T1 AT98919870T AT98919870T ATE438657T1 AT E438657 T1 ATE438657 T1 AT E438657T1 AT 98919870 T AT98919870 T AT 98919870T AT 98919870 T AT98919870 T AT 98919870T AT E438657 T1 ATE438657 T1 AT E438657T1
Authority
AT
Austria
Prior art keywords
proteins
nucleic acid
polypeptides
antibodies
acid molecules
Prior art date
Application number
AT98919870T
Other languages
English (en)
Inventor
Cheryl Murphy
James Storey
Gerald Beltz
Richard Coughlin
Original Assignee
Antigenics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antigenics Inc filed Critical Antigenics Inc
Application granted granted Critical
Publication of ATE438657T1 publication Critical patent/ATE438657T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/29Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT98919870T 1997-04-25 1998-04-24 Charakterisierung von granulozytischer ehrlichia und methoden für ihre verwendung. ATE438657T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4493397P 1997-04-25 1997-04-25
PCT/US1998/008265 WO1998049313A2 (en) 1997-04-25 1998-04-24 Characterization of granulocytic ehrlichia and methods of use

Publications (1)

Publication Number Publication Date
ATE438657T1 true ATE438657T1 (de) 2009-08-15

Family

ID=21935120

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98919870T ATE438657T1 (de) 1997-04-25 1998-04-24 Charakterisierung von granulozytischer ehrlichia und methoden für ihre verwendung.

Country Status (8)

Country Link
US (5) US6204252B1 (de)
EP (3) EP2311957A1 (de)
AT (1) ATE438657T1 (de)
AU (1) AU7256398A (de)
CA (1) CA2258277C (de)
DE (1) DE69841037D1 (de)
ES (1) ES2330393T3 (de)
WO (1) WO1998049313A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277381B1 (en) 1997-03-21 2001-08-21 Corixa Corporation Compounds and methods for the diagnosis and treatment of Ehrlichia infection
US6207169B1 (en) 1997-03-21 2001-03-27 Corixa Corporation Compounds and methods for the diagnosis and treatment of Ehrlichia infection
US6231869B1 (en) 1997-03-21 2001-05-15 Corixa Corporation Compounds and methods for the diagnosis and treatment of ehrlichia infection
US6673356B1 (en) 1997-03-21 2004-01-06 Corixa Corporation Compounds and methods for the diagnosis and treatment of ehrlichia infection
WO1998049313A2 (en) * 1997-04-25 1998-11-05 Aquila Biopharmaceuticals, Inc. Characterization of granulocytic ehrlichia and methods of use
EP1100917A1 (de) * 1998-07-28 2001-05-23 Aquila Biopharmaceuticals, Inc. Granulocytic ehrlichia genen und ihre verwendungen
US7407770B2 (en) * 2001-01-18 2008-08-05 Idexx Corporation Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US20030194756A1 (en) 2002-04-12 2003-10-16 O'connor Thomas Patrick Peptides for detection of antibody to Ehrlichia equi
US7087372B2 (en) * 2001-01-18 2006-08-08 Idexx Laboratories, Inc. Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US7183060B2 (en) * 2005-02-22 2007-02-27 Idexx Laboratories, Inc. Peptides for detection of antibody to Ehrlichia ewingii
US20030129680A1 (en) * 2001-10-31 2003-07-10 O'connor Thomas Patrick Multi-analyte assay device
BRPI0706436A2 (pt) * 2006-01-05 2011-03-29 Medical Instill Tech Inc válvula unidirecional e aparelho e método de uso da mesma
US7507789B2 (en) * 2007-04-09 2009-03-24 Idexx Laboratories, Inc. Detection of Anaplasma platys
US7964366B2 (en) * 2007-09-21 2011-06-21 Idexx Laboratories, Inc. Methods and compositions for detection of Ehrlichia chaffeensis (VLPT)
MX2010002947A (es) * 2007-09-21 2010-08-04 Idexx Lab Inc Metodos y composiciones para deteccion de ehrlichia chaffeensis (p120).
US8158370B2 (en) * 2007-11-27 2012-04-17 Idexx Laboratories, Inc. Anaplasma phagocytophilum (Aph) antigens and antibodies specific for Anaplasma
MX2011003634A (es) 2008-10-08 2011-05-02 Idexx Lab Inc Composiciones y metodos para la deteccion de anticuerpos especificos de anaplasma phagocytophilum (aph) y anaplasma platys (apl).
KR101892182B1 (ko) * 2009-11-20 2018-08-24 아박시스, 인크. 에를리키아 항체의 검출을 위한 펩티드, 장치 및 방법
WO2013067448A2 (en) 2011-11-03 2013-05-10 Vca Antech Inc. Compositions and methods to detect various infectious organisms
WO2013113000A2 (en) 2012-01-26 2013-08-01 Luc Montagnier Detection of dna sequences as risk factors for hiv infection
US20130236898A1 (en) * 2012-03-09 2013-09-12 Charles A. Kallick Anaplasma FAMILY MEMBERS CAUSE A NUMBER OF BLOOD-BORNE DISEASES
EP2906950B1 (de) 2012-10-11 2018-03-21 Abaxis, Inc. Peptide, vorrichtungen und verfahren zum nachweis von ehrlichia-antikörpern
US9194870B2 (en) 2014-01-21 2015-11-24 Abaxis, Inc. Peptides, devices, and methods for the detection of Anaplasma antibodies
US9442112B2 (en) 2014-04-04 2016-09-13 Abaxis, Inc. Compositions and methods for identifying Ehrlichia species
BR112018005825B1 (pt) * 2015-11-02 2022-05-17 Halliburton Energy Services, Inc Método e sistema de fraturamento e de embalagem de cascalho

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235877A (en) 1979-06-27 1980-11-25 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (de) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimäre Rezeptoren durch Verbindung und Expression von DNS
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
JPS63501765A (ja) 1985-11-01 1988-07-21 インタ−ナショナル、ジェネティック、エンジニアリング インコ−ポレ−テッド 抗体遺伝子のモジュ−ル組立体、それにより産生された抗体及び用途
US5047540A (en) 1987-12-17 1991-09-10 Shionogi & Co., Ltd. Lipid derivatives
US5976860A (en) * 1995-06-06 1999-11-02 Aquila Biopharmaceuticals, Inc. Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods
US6284238B1 (en) 1995-06-06 2001-09-04 Aquila Biopharmaceuticals, Inc. Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods
US6015691A (en) 1996-05-31 2000-01-18 Research Development Foundation Immunodominant 120 kDa surface-exposed adhesion protein genes of Ehrlichia chaffeensis
EP0932680A2 (de) * 1996-10-01 1999-08-04 Yale University Zusammensetzungen und methoden zur verhinderung und diagnose der humanen granulozytischen ehrlichiose
US6277381B1 (en) 1997-03-21 2001-08-21 Corixa Corporation Compounds and methods for the diagnosis and treatment of Ehrlichia infection
US6207169B1 (en) * 1997-03-21 2001-03-27 Corixa Corporation Compounds and methods for the diagnosis and treatment of Ehrlichia infection
US6231869B1 (en) 1997-03-21 2001-05-15 Corixa Corporation Compounds and methods for the diagnosis and treatment of ehrlichia infection
WO1998049313A2 (en) * 1997-04-25 1998-11-05 Aquila Biopharmaceuticals, Inc. Characterization of granulocytic ehrlichia and methods of use
WO1998049312A2 (en) * 1997-04-25 1998-11-05 Aquila Biopharmaceuticals, Inc. Nucleic acids, proteins, and methods of use of granulocytic erhlichia
CA2326717A1 (en) 1998-04-09 1999-10-21 The Ohio State Research Foundation Nucleic acids encoding outer membrane protein of human granulocytic ehrlichiosis agent
EP1100917A1 (de) 1998-07-28 2001-05-23 Aquila Biopharmaceuticals, Inc. Granulocytic ehrlichia genen und ihre verwendungen
IT1395574B1 (it) 2009-09-14 2012-10-16 Guala Dispensing Spa Dispositivo di erogazione
US9610117B2 (en) 2010-04-29 2017-04-04 Dfine, Inc. System for use in treatment of vertebral fractures
WO2016048650A1 (en) 2014-09-22 2016-03-31 Schaeffler Technologies AG & Co. KG Hybrid drive module with single damper

Also Published As

Publication number Publication date
EP2060631A3 (de) 2009-07-15
ES2330393T3 (es) 2009-12-09
US8093008B2 (en) 2012-01-10
WO1998049313A3 (en) 1999-01-14
US20110045605A1 (en) 2011-02-24
CA2258277A1 (en) 1998-11-05
US20120178102A1 (en) 2012-07-12
AU7256398A (en) 1998-11-24
EP2311957A1 (de) 2011-04-20
US8461323B2 (en) 2013-06-11
US7863434B2 (en) 2011-01-04
EP0915980A2 (de) 1999-05-19
US6204252B1 (en) 2001-03-20
CA2258277C (en) 2013-08-13
DE69841037D1 (de) 2009-09-17
WO1998049313A2 (en) 1998-11-05
EP0915980B1 (de) 2009-08-05
US8435495B2 (en) 2013-05-07
EP2060631A2 (de) 2009-05-20
US20100088774A1 (en) 2010-04-08
US20120270232A1 (en) 2012-10-25

Similar Documents

Publication Publication Date Title
ATE438657T1 (de) Charakterisierung von granulozytischer ehrlichia und methoden für ihre verwendung.
ATE426018T1 (de) Pca3, pca3-gene und verfahren zu ihrer verwendung
Harper et al. The purification of nerve growth factor from bovine seminal plasma. Biochemical characterization and partial amino acid sequence.
DK169724B1 (da) Fremgangsmåde til fremstilling af et polypeptidfragment af faktor VIII:C, DNA-sekvens, som koder herfor, og ekstrachromosomalt element indeholdende en sådan DNA-sekvens
DK0868519T3 (da) Diagnose og behandling af AUR-1- og/eller AUR-2-relaterede lidelser
DE60140773D1 (de) Polypeptide zur Bindung an das B-Lymphozyten-stimulatorische Protein (BLyS)
DE60026332D1 (de) Diagnose von einheimischer sprue/zöliakie mit hilfe von gliadinepitopen
ATE209356T1 (de) Ein verfahren zur bestimmung von kollagenfragmenten in körperflüssigkeiten, ein testkit und mittel zur durchführung des verfahrens, und seine verwendung zur feststellung von mit dem kollagenmetabolismus assoziierten störungen
WO1998057984A3 (en) Torsin, torsin genes, and methods of use
DE69535921D1 (de) Alk-7 (aktivin-rezeptor-ähnliche kinase), ein serin/threonin kinase rezeptor
ES2079621T3 (es) Procedimiento de identificacion o de titulacion de proteinas y aplicaciones.
ATE350398T1 (de) Protein s polypeptide und deren verwendungen
Grant et al. Mapping Functional Domains of Human Platelet Thrombospondin with Electro-Blotting and High Sensitivity Sequencing

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties